186 related articles for article (PubMed ID: 32770172)
1. Berberine improves intralipid-induced insulin resistance in murine.
Dong ZH; Lin HY; Chen FL; Che XQ; Bi WK; Shi SL; Wang J; Gao L; He Z; Zhao JJ
Acta Pharmacol Sin; 2021 May; 42(5):735-743. PubMed ID: 32770172
[TBL] [Abstract][Full Text] [Related]
2. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
3. Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling.
Høeg LD; Sjøberg KA; Jeppesen J; Jensen TE; Frøsig C; Birk JB; Bisiani B; Hiscock N; Pilegaard H; Wojtaszewski JF; Richter EA; Kiens B
Diabetes; 2011 Jan; 60(1):64-73. PubMed ID: 20956497
[TBL] [Abstract][Full Text] [Related]
4. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
6. A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats.
Gu JJ; Gao FY; Zhao TY
J Physiol Pharmacol; 2012 Oct; 63(5):505-13. PubMed ID: 23211304
[TBL] [Abstract][Full Text] [Related]
7. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
[TBL] [Abstract][Full Text] [Related]
8. Exercise alleviates lipid-induced insulin resistance in human skeletal muscle-signaling interaction at the level of TBC1 domain family member 4.
Pehmøller C; Brandt N; Birk JB; Høeg LD; Sjøberg KA; Goodyear LJ; Kiens B; Richter EA; Wojtaszewski JF
Diabetes; 2012 Nov; 61(11):2743-52. PubMed ID: 22851577
[TBL] [Abstract][Full Text] [Related]
9. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
10. Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.
Chang W; Zhang M; Li J; Meng Z; Wei S; Du H; Chen L; Hatch GM
Metabolism; 2013 Aug; 62(8):1159-67. PubMed ID: 23537779
[TBL] [Abstract][Full Text] [Related]
11. Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway.
Xu J; Zhang Y; Yu Z; Guan Y; Lv Y; Zhang M; Zhang M; Chen L; Lv X; Guan F
Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 54(10):1464-1475. PubMed ID: 36269134
[TBL] [Abstract][Full Text] [Related]
12. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
13. Berberine inhibits PTP1B activity and mimics insulin action.
Chen C; Zhang Y; Huang C
Biochem Biophys Res Commun; 2010 Jul; 397(3):543-7. PubMed ID: 20515652
[TBL] [Abstract][Full Text] [Related]
14. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
[TBL] [Abstract][Full Text] [Related]
15. Nanoemulsion improves hypoglycemic efficacy of berberine by overcoming its gastrointestinal challenge.
Xu HY; Liu CS; Huang CL; Chen L; Zheng YR; Huang SH; Long XY
Colloids Surf B Biointerfaces; 2019 Sep; 181():927-934. PubMed ID: 31382342
[TBL] [Abstract][Full Text] [Related]
16. Berberine attenuates obesity-induced insulin resistance by inhibiting miR-27a secretion.
Du J; Zhu Y; Yang X; Geng X; Xu Y; Zhang M; Zhang M
Diabet Med; 2024 Jul; 41(7):e15319. PubMed ID: 38711201
[TBL] [Abstract][Full Text] [Related]
17. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis.
Gomes AP; Duarte FV; Nunes P; Hubbard BP; Teodoro JS; Varela AT; Jones JG; Sinclair DA; Palmeira CM; Rolo AP
Biochim Biophys Acta; 2012 Feb; 1822(2):185-95. PubMed ID: 22027215
[TBL] [Abstract][Full Text] [Related]
18. Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes.
Chang W; Chen L; Hatch GM
Biochim Biophys Acta; 2016 Apr; 1861(4):352-62. PubMed ID: 26774040
[TBL] [Abstract][Full Text] [Related]
19. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway.
Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z
Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028
[TBL] [Abstract][Full Text] [Related]
20. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
